Philip W Kantoff Selected Research

VA 061 (VA061)

9/2006	Response to low-dose ketoconazole and subsequent dose escalation to high-dose ketoconazole in patients with androgen-independent prostate cancer.
10/2005	Efficacy of nilutamide as secondary hormonal therapy in androgen-independent prostate cancer.
12/2004	Genotyping and functional analysis of the D104N variant of human endostatin.
9/2004	Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer.
7/2003	Finasteride and flutamide therapy in patients with advanced prostate cancer: response to subsequent castration and long-term follow-up.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip W Kantoff Research Topics

Disease

257	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
127	Neoplasms (Cancer) 01/2022 - 01/2002
25	Neoplasm Metastasis (Metastasis) 01/2022 - 02/2002
11	Carcinoma (Carcinomatosis) 01/2016 - 02/2002
10	Leukemia 01/2019 - 04/2003
9	Carcinogenesis 11/2015 - 05/2002
8	Disease Progression 01/2018 - 10/2004
6	Adenocarcinoma 06/2013 - 04/2003
5	Inflammation (Inflammations) 01/2020 - 11/2012
5	7 Hereditary Prostate Cancer 05/2016 - 05/2009
4	Pain (Aches) 05/2021 - 05/2008
4	Fatigue 01/2020 - 06/2018
3	Breast Neoplasms (Breast Cancer) 09/2017 - 02/2002
3	Residual Neoplasm 05/2017 - 11/2014
3	Renal Cell Carcinoma (Grawitz Tumor) 11/2015 - 01/2002
2	Circulating Neoplastic Cells 01/2020 - 05/2014
2	Hypertension (High Blood Pressure) 01/2019 - 01/2016
2	Obesity 11/2017 - 01/2014

Drug/Important Bio-Agent (IBA)

86	AndrogensIBA 10/2021 - 02/2002
59	Prostate-Specific Antigen (Semenogelase)IBA 01/2022 - 02/2002
38	Hormones (Hormone)IBA 03/2018 - 01/2002
27	Androgen Receptors (Androgen Receptor)IBA 12/2020 - 02/2002
26	Biomarkers (Surrogate Marker)IBA 12/2021 - 10/2003
20	Proteins (Proteins, Gene)FDA Link 12/2021 - 12/2004
20	sipuleucel-T (APC8015)FDA Link 01/2020 - 07/2010
16	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 12/2003
14	Docetaxel (Taxotere)FDA Link 10/2021 - 01/2005
13	Biological ProductsIBA 01/2022 - 03/2002
12	Abiraterone AcetateIBA 01/2021 - 09/2012
10	Testosterone (Sustanon)FDA Link 01/2021 - 07/2003
10	enzalutamideIBA 01/2021 - 05/2015
9	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2006
8	Messenger RNA (mRNA)IBA 01/2022 - 06/2003
8	SteroidsIBA 01/2020 - 01/2002
8	AntigensIBA 01/2016 - 04/2006
7	Pharmaceutical PreparationsIBA 01/2022 - 10/2007
6	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2003
6	PlatinumIBA 01/2020 - 02/2012
6	EnzymesIBA 01/2019 - 01/2002
6	SeleniumIBA 05/2016 - 03/2005
6	thiamine triphosphorate (TTP)IBA 02/2016 - 07/2005
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 07/2015
5	abirateroneIBA 06/2018 - 03/2015
5	Leuprolide (Lupron)FDA LinkGeneric 01/2018 - 02/2002
5	Dutasteride (Avodart)FDA Link 05/2017 - 10/2009
5	Gonadotropin-Releasing Hormone (GnRH)FDA Link 05/2017 - 02/2002
5	VaccinesIBA 01/2016 - 03/2010
5	Ketoconazole (Nizoral)FDA LinkGeneric 03/2015 - 09/2006
5	Androgen Antagonists (Antiandrogens)IBA 07/2012 - 07/2003
5	Estrogens (Estrogen)FDA Link 12/2011 - 01/2002
5	VA 061 (VA061)IBA 09/2006 - 07/2003
4	Formaldehyde (Formol)FDA Link 11/2020 - 08/2014
4	ParaffinIBA 11/2020 - 08/2014
4	Immune Checkpoint InhibitorsIBA 04/2019 - 08/2011
4	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2009
4	PROSTVACIBA 01/2019 - 08/2011
4	Carboplatin (JM8)FDA LinkGeneric 09/2017 - 01/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2004
3	Serine Proteases (Serine Protease)IBA 01/2022 - 06/2008
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 01/2020
3	NucleotidesIBA 01/2022 - 08/2003
3	Calcitriol Receptors (Calcitriol Receptor)IBA 01/2019 - 10/2003
3	LipidsIBA 01/2019 - 04/2015
3	Prednisone (Sone)FDA LinkGeneric 01/2019 - 07/2017
3	Radium-223IBA 01/2019 - 12/2013
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2018 - 12/2007
3	cabozantinibIBA 06/2018 - 11/2015
3	Bevacizumab (Avastin)FDA Link 01/2016 - 10/2012
3	Everolimus FDA Link 11/2015 - 12/2012
3	AntioxidantsIBA 08/2015 - 03/2005
3	Flutamide (Eulexin)FDA LinkGeneric 03/2015 - 07/2003
3	AutoantigensIBA 11/2012 - 08/2011
3	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2011 - 05/2005
3	Peptides (Polypeptides)IBA 05/2011 - 09/2005
3	LigandsIBA 03/2011 - 10/2003
3	Finasteride (Propecia)FDA LinkGeneric 02/2004 - 07/2003
2	Dasatinib (BMS 354825)FDA Link 01/2022 - 01/2021
2	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 01/2020 - 01/2019
2	TensinsIBA 01/2020 - 11/2018
2	BRCA1 ProteinIBA 01/2020 - 04/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 11/2018
2	Histones (Histone)IBA 01/2019 - 01/2018
2	Denosumab FDA Link 01/2019 - 05/2015
2	25-hydroxyvitamin DIBA 01/2019 - 06/2011
2	Vitamin D FDA LinkGeneric 01/2019 - 06/2011
2	CD100 antigenIBA 01/2019 - 11/2012
2	hydroxide ionIBA 01/2019 - 06/2011
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2018 - 02/2003
2	Long Noncoding RNAIBA 03/2018 - 03/2016
2	Lysine (L-Lysine)FDA Link 01/2018 - 05/2016
2	ChromatinIBA 11/2017 - 01/2014

Therapy/Procedure

106	Therapeutics 01/2022 - 02/2002
82	Castration 01/2022 - 07/2003
25	Drug Therapy (Chemotherapy) 01/2020 - 09/2002
22	Radiotherapy 01/2021 - 06/2003
20	Prostatectomy (Retropubic Prostatectomy) 04/2018 - 11/2003
18	Immunotherapy 12/2019 - 03/2010
5	Aftercare (After-Treatment) 01/2020 - 06/2008
5	Brachytherapy 09/2012 - 11/2003
4	Neoadjuvant Therapy 05/2017 - 01/2006